OIL

0.00%

17.0¢ optiscan imaging limited

You seem to be describing the ViewnVivo. This device has been...

First 4 Last

Share
Profile

Follow
BuffettWarren

1,828 Posts.

207

09/06/24

22:47

Post #: 74239919
Share

Originally posted by ingenue2: ↑

Although OIL have always been, pardon the pun, laser-focussed on developing their tech for medical instruments, did they ever, at least in the early days, explore other fields, non-medical related, as possible markets for development and application of their technology? Sorry as that may be a dumb question as nothing immediately springs to my mediocre mind. Still...does anybody here know?

Also, can our current products be used for scientific research that does not require FDA approval? Can the tech be modified in the future for biological research of non-human subjects that bypasses the need for FDA approval?

I know the medical applications are the obvious case, and there are enough possibilities to explore and develop in the medical field in the immediate future. But are there other commercial areas where it can be adapted and applied?

In veterinary science (I'm thinking for research labs in universities, not in vet clinic!) I'm sure it would come into use and a uni would stump up for the price. Although not as lucrative, wouldn't it have been an easier path to actually selling products in the first case, as presumably this would not have required as stringent approvals, such as what the FDA requires for the human medical field? This is only in hindsight, considering HOW LONG the FDA process has been in some cases.

These are all probably very dumb questions,but I have always wanted to ask to get some clarity, so any insights would be greatly appreciated..

I guess these questions shouldn't be under Tiresias's thread, but I'm hoping the great Seer might peer down from Mount Olympus and provide a few insights himself ;-)

Expand

You seem to be describing the ViewnVivo. This device has been selling for a few years now.

https://www.optiscan.com/products/viewnvivo

OIL Price at posting: 15.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

First 4 Last

Add OIL (ASX) to my watchlist

(20min delay)
Last 17.0¢		Change 0.000(0.00%)		Mkt cap ! $142.0M

Open	High	Low	Value	Volume
16.5¢	17.0¢	16.0¢	$3.653K	22.39K

Buyers (Bids)

No.	Vol.	Price($)
3	72624	16.0¢

Sellers (Offers)

Price($)	Vol.	No.
17.0¢	56888	2

View Market Depth

No.	Vol.	Price($)
3	72624	0.160
2	29026	0.155
6	81299	0.150
1	5000	0.145
2	57135	0.140

Price($)	Vol.	No.
0.170	56888	2
0.180	123689	3
0.185	132650	4
0.190	30000	1
0.195	268571	3

Last trade - 11.46am 15/11/2024 (20 minute delay)

OIL (ASX) Chart

You seem to be describing the ViewnVivo. This device has been...

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Cyclone signs MOU with Vale for development of Iron Bear play

Banshee's historic trenches prove rich in antimony and gold for GDM

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

You seem to be describing the ViewnVivo. This device has been...

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Cyclone signs MOU with Vale for development of Iron Bear play

Banshee's historic trenches prove rich in antimony and gold for GDM

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News